150 related articles for article (PubMed ID: 26372488)
1. The HIV care cascade in Switzerland: reaching the UNAIDS/WHO targets for patients diagnosed with HIV.
Kohler P; Schmidt AJ; Cavassini M; Furrer H; Calmy A; Battegay M; Bernasconi E; Ledergerber B; Vernazza P;
AIDS; 2015 Nov; 29(18):2509-15. PubMed ID: 26372488
[TBL] [Abstract][Full Text] [Related]
2. Cascade of HIV care and population viral suppression in a high-burden region of Kenya.
Maman D; Zeh C; Mukui I; Kirubi B; Masson S; Opolo V; Szumilin E; Riche B; Etard JF
AIDS; 2015 Jul; 29(12):1557-65. PubMed ID: 26244395
[TBL] [Abstract][Full Text] [Related]
3. Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study.
Drescher SM; von Wyl V; Yang WL; Böni J; Yerly S; Shah C; Aubert V; Klimkait T; Taffé P; Furrer H; Battegay M; Ambrosioni J; Cavassini M; Bernasconi E; Vernazza PL; Ledergerber B; Günthard HF; Kouyos RD;
Clin Infect Dis; 2014 Jan; 58(2):285-94. PubMed ID: 24145874
[TBL] [Abstract][Full Text] [Related]
4. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States.
Hall HI; Frazier EL; Rhodes P; Holtgrave DR; Furlow-Parmley C; Tang T; Gray KM; Cohen SM; Mermin J; Skarbinski J
JAMA Intern Med; 2013 Jul; 173(14):1337-44. PubMed ID: 23780395
[TBL] [Abstract][Full Text] [Related]
5. Clinical epidemiology and research on HIV infection in Switzerland: the Swiss HIV Cohort Study 1988-2000.
Sudre P; Rickenbach M; Taffé P; Janin P; Volkart AC; Francioli P;
Schweiz Med Wochenschr; 2000 Oct; 130(41):1493-500. PubMed ID: 11075414
[TBL] [Abstract][Full Text] [Related]
6. Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort Analysis.
Scherrer AU; von Wyl V; Yang WL; Kouyos RD; Böni J; Yerly S; Klimkait T; Aubert V; Cavassini M; Battegay M; Furrer H; Calmy A; Vernazza P; Bernasconi E; Günthard HF; ; Aubert V; Battegay M; Bernasconi E; Böni J; Braun DL; Bucher HC; Burton-Jeangros C; Calmy A; Cavassini M; Dollenmaier G; Egger M; Elzi L; Fehr J; Fellay J; Furrer H; Fux CA; Gorgievski M; Günthard H; Haerry D; Hasse B; Hirsch HH; Hoffmann M; Hösli I; Kahlert C; Kaiser L; Keiser O; Klimkait T; Kouyos R; Kovari H; Ledergerber B; Martinetti G; Martinez de Tejada B; Marzolini C; Metzner K; Müller N; Nadal D; Nicca D; Pantaleo G; Rauch A; Regenass S; Rudin C; Schöni-Affolter F; Schmid P; Speck R; Stöckle M; Tarr P; Trkola A; Vernazza P; Weber R; Yerly S
Clin Infect Dis; 2016 May; 62(10):1310-1317. PubMed ID: 26962075
[TBL] [Abstract][Full Text] [Related]
7. Influence of noninjecting and injecting drug use on mortality, retention in the cohort, and antiretroviral therapy, in participants in the Swiss HIV Cohort Study.
Weber R; Huber M; Battegay M; Stähelin C; Castro Batanjer E; Calmy A; Bregenzer A; Bernasconi E; Schoeni-Affolter F; Ledergerber B;
HIV Med; 2015 Mar; 16(3):137-51. PubMed ID: 25124393
[TBL] [Abstract][Full Text] [Related]
8. HIV cascade of care in Greece: Useful insights from additional stages.
Vourli G; Nikolopoulos G; Paparizos V; Skoutelis A; Metallidis S; Gargalianos P; Papadopoulos A; Chini M; Sipsas NV; Psychogiou M; Chrysos G; Sambatakou H; Gogos C; Katsarou O; Paraskeva D; Dedes N; Touloumi G;
PLoS One; 2018; 13(11):e0207355. PubMed ID: 30440000
[TBL] [Abstract][Full Text] [Related]
9. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
[TBL] [Abstract][Full Text] [Related]
10. Vital signs: HIV prevention through care and treatment--United States.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(47):1618-23. PubMed ID: 22129997
[TBL] [Abstract][Full Text] [Related]
11. Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study.
Glass TR; Weber R; Vernazza PL; Rickenbach M; Furrer H; Bernasconi E; Cavassini M; Hirschel B; Battegay M; Bucher HC;
HIV Clin Trials; 2007; 8(2):77-85. PubMed ID: 17507323
[TBL] [Abstract][Full Text] [Related]
12. Uptake of and virological response to antiretroviral therapy among HIV-infected former and current injecting drug users and persons in an opiate substitution treatment programme: the Swiss HIV Cohort Study.
Weber R; Huber M; Rickenbach M; Furrer H; Elzi L; Hirschel B; Cavassini M; Bernasconi E; Schmid P; Ledergerber B;
HIV Med; 2009 Aug; 10(7):407-16. PubMed ID: 19490174
[TBL] [Abstract][Full Text] [Related]
13. Impact of highly active antiretroviral therapy on the molecular epidemiology of newly diagnosed HIV infections.
Ambrosioni J; Junier T; Delhumeau C; Calmy A; Hirschel B; Zdobnov E; Kaiser L; Yerly S;
AIDS; 2012 Oct; 26(16):2079-86. PubMed ID: 23052354
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes.
Fenner L; Gagneux S; Janssens JP; Fehr J; Cavassini M; Hoffmann M; Bernasconi E; Schrenzel J; Bodmer T; Böttger EC; Helbling P; Egger M;
PLoS One; 2012; 7(3):e34186. PubMed ID: 22479556
[TBL] [Abstract][Full Text] [Related]
15. [The Swiss HIV Cohort Study--a link between clinical research and medical practice].
Opravil M; Rickenbach M; Ledergerber B
Ther Umsch; 1998 May; 55(5):329-34. PubMed ID: 9643131
[TBL] [Abstract][Full Text] [Related]
16. Genotypic Resistance Tests Sequences Reveal the Role of Marginalized Populations in HIV-1 Transmission in Switzerland.
Shilaih M; Marzel A; Yang WL; Scherrer AU; Schüpbach J; Böni J; Yerly S; Hirsch HH; Aubert V; Cavassini M; Klimkait T; Vernazza PL; Bernasconi E; Furrer H; Günthard HF; Kouyos R;
Sci Rep; 2016 Jun; 6():27580. PubMed ID: 27297284
[TBL] [Abstract][Full Text] [Related]
17. Improved retention associated with community-based accompaniment for antiretroviral therapy delivery in rural Rwanda.
Franke MF; Kaigamba F; Socci AR; Hakizamungu M; Patel A; Bagiruwigize E; Niyigena P; Walker KD; Epino H; Binagwaho A; Mukherjee J; Farmer PE; Rich ML
Clin Infect Dis; 2013 May; 56(9):1319-26. PubMed ID: 23249611
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus transmission at each step of the care continuum in the United States.
Skarbinski J; Rosenberg E; Paz-Bailey G; Hall HI; Rose CE; Viall AH; Fagan JL; Lansky A; Mermin JH
JAMA Intern Med; 2015 Apr; 175(4):588-96. PubMed ID: 25706928
[TBL] [Abstract][Full Text] [Related]
19. Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study.
Ledergerber B; Cavassini M; Battegay M; Bernasconi E; Vernazza P; Hirschel B; Furrer H; Rickenbach M; Weber R;
HIV Med; 2011 May; 12(5):279-88. PubMed ID: 20955356
[TBL] [Abstract][Full Text] [Related]
20. Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality.
Glass TR; Sterne JA; Schneider MP; De Geest S; Nicca D; Furrer H; Günthard HF; Bernasconi E; Calmy A; Rickenbach M; Battegay M; Bucher HC;
AIDS; 2015 Oct; 29(16):2195-200. PubMed ID: 26544582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
